Hua Tian
- Oncology top 1%
- Cancer Cells and Metastasis 9
- Cancer Research top 2%
- Molecular Biology top 1%
- RNA modifications and cancer 11
- Ubiquitin and proteasome pathways 9
- PI3K/AKT/mTOR signaling in cancer 8
- Hedgehog Signaling Pathway Studies 8
- dental development and anomalies 8
- Histone Deacetylase Inhibitors Research 7
- Developmental Biology top 5%
- Genetics top 2%
-
- Bone and Dental Protein Studies 8
- Co-authors
- Frédéric J. de SauvageOphir D. KleinClifford J. TabinAndrew P. McMahonBrian D. HarfeBrian BiehsSahar NissimPaul Scherz
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hua Tian
114 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.7k
- Cancer Research 955
- Molecular Biology 4.0k
- Developmental Biology 96
- Genetics 782
Countries citing papers authored by Hua Tian
This map shows the geographic impact of Hua Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Tian more than expected).
Fields of papers citing papers by Hua Tian
This network shows the impact of papers produced by Hua Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Tian. The network helps show where Hua Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hua Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 7 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 15 | |
| 10 | 2021 | 31 | |
| 11 | 2020 | 76 | |
| 12 | 2020 | 39 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 37 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 55 | |
| 17 | The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma. | 2017 | 19 |
| 18 | 2013 | 56 | |
| 19 | 2009 | 332 | |
| 20 | 1996 | 41 |
About Hua Tian
Hua Tian is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 121 papers that have together received 5.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Ubiquitin and proteasome pathways (9 papers), Cancer Cells and Metastasis (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Hedgehog Signaling Pathway Studies (8 papers), Bone and Dental Protein Studies (8 papers), dental development and anomalies (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (955 citations) and Molecular Biology (4.0k citations). Hua Tian has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Frédéric J. de Sauvage, Ophir D. Klein, Clifford J. Tabin, Andrew P. McMahon, Brian D. Harfe, Brian Biehs, Sahar Nissim, Paul Scherz, Søren Warming and Linda Rangell. Their work appears in journals such as Oncotarget, Journal of Medicinal Chemistry, Oncogene, Cancer Letters and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.